More about marijuana

September 23, 2012

Marijuana seems to help some patients with migraine and cluster headaches. However a new study suggests that it has more negative effects than previously thought. We know that smoking pot causes lung problems and risks serious damage to various organs due to possible impurities. A recent report in the Proceedings of the National Academy of Sciences shows that regular cannabis use is harmful to health. Adolescents are beginning to use marijuana at younger ages, and more adolescents are using it on a daily basis. This study showed that persistent use of marijuana leads to neuropsychological decline. Researchers from Duke University, England and New Zealand examined records of 1,037 individuals who were followed from birth to age 38. Marijuana use was determined in interviews at ages 18, 21, 26, 32, and 38. Neuropsychological testing was conducted at age 13, before initiation of marijuana use, and again at age 38. Persistent use was associated with neuropsychological decline, including IQ, even after taking into account years of education. Persistent marijuana users reported noticing more cognitive problems. Impairment was strongest among those who started using marijuana in adolescence and the more persistent was the use the greater was the cognitive decline. Stopping marijuana use did not fully restore neuropsychological functioning and IQ among those who started its use in adolescence. This study suggests that cannabis has a toxic an persistent effect on the adolescent brain.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe